DS
THRD

David Shaw’s Third Harmonic Bio THRD Stock Holding History

David Shaw’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,250,680
Closed -$6.79M – 4929
2025
Q2 		$6.79M Buy
1,250,680
+677,346
+118% +$3.38M ﹤0.01% 1795
2025
Q1 		$1.99M Buy
573,334
+562,334
+5,112% +$2.73M ﹤0.01% 2599
2024
Q4 		$113K Sell
11,000
-2,967
-21% -$37K ﹤0.01% 4158
2024
Q3 		$189K Buy
+13,967
New +$173K ﹤0.01% 4173
2024
Q2 		– Sell
-28,974
Closed -$274K – 4838
2024
Q1 		$274K Buy
28,974
+2,213
+8% +$21.5K ﹤0.01% 3778
2023
Q4 		$294K Buy
+26,761
New +$212K ﹤0.01% 3751

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $22.1B AUM 45.54% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

David Shaw's THRD Position: Q3 2025 in Review

David Shaw sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 1,250,680 shares — an estimated $6.79M sold.

David Shaw first reported a position in THRD in Q4 2023 and held it in 6 quarters. The position peaked at $6.79M in Q2 2025. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • David Shaw reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • David Shaw sold 1,250,680 Third Harmonic Bio shares in Q3 2025, an estimated $6.79M.
  • David Shaw first reported a position in Third Harmonic Bio in Q4 2023 and held it in 6 quarters.
  • David Shaw's Third Harmonic Bio position peaked at $6.79M in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.